Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00499408 · ClinicalTrials.gov registry record · Phase 2
Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate Cancer
A Phase 2 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 2
- Development phase
- 26
- Enrollment target
NCT00499408 is a Phase 2 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 26 participants.
The verdict
NCT00499408, a Phase 2 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 26 participants
- Enrollment target
Study Summary
RATIONALE: Vitamin D and soy extract may be effective in lowering prostate-specific antigen (PSA) levels in patients with recurrent prostate cancer that has not responded to previous treatment. PURPOSE: This phase II trial is studying how well giving vitamin D together with soy supplements works in treating patients with recurrent prostate cancer.
Interventions
- DIETARY_SUPPLEMENT Vitamin D
- DIETARY_SUPPLEMENT soy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2007-04 |
| Est. Completion | 2012-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00499408
The ClinicalTrials.gov registry entry for NCT00499408 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vitamin D is the first listed.
NCT00499408 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00499408 about?
NCT00499408 is a clinical study titled "Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate Cancer". RATIONALE: Vitamin D and soy extract may be effective in lowering prostate-specific antigen (PSA) levels in patients with recurrent prostate cancer that has not responded to previous treatment. PURPOSE: This phase II trial is studying how well giving vitamin D together with soy supplements works in...
What is the current status of trial NCT00499408?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 26 participants. The study started on 2007-04. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00499408?
The interventions under investigation include: Vitamin D (DIETARY_SUPPLEMENT), soy (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00499408?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.